Select Language
Functional Cell Line Commercial License Support Service
As an essential tool in biopharmaceutical research and development, functional cell lines offer stability, broad applicability, and rich biological characteristics, making them extensively used in target validation, mechanism exploration, high-throughput drug screening, analytical testing, quality control (QC) release, as well as pharmacodynamics and toxicology studies. In the biopharmaceutical development process, obtaining commercial licensing for functional cell line products is a critical prerequisite to ensure the legal and compliant advancement of projects.
ACROBiosystems has officially secured global commercial usage rights for HEK293, CHO, Jurkat, Raji cell lines, enabling it to provide comprehensive licensing support and services worldwide. This strategic achievement significantly enhances ACROBiosystems' portfolio of functional cell line products and services, offering biopharmaceutical developers and CRO/CDMO partners robust regulatory and intellectual property assurance. By offering this critical support, ACROBiosystems empowers its partners across the entire drug development process—from early-stage research and regulatory submissions to successful commercialization — ensuring a seamless and compliant pathway for innovation and market entry.
Core Value
ACROBiosystems' functional cell line license support service is designed to assist biopharmaceutical developers and CRO/CDMO partners in obtaining commercial licenses for cell line products in a legally compliant manner. From the outset of a project, this service helps customers mitigate intellectual property and compliance risks, ensuring the use of properly authorized cell lines. By preventing the utilization of unclear or unauthorized cell lines, it safeguards against potential disruptions to commercialization and technology transfer, which could otherwise result in significant financial and operational setbacks. Moreover, this service contributes to accelerating drug development timelines and reducing associated costs.
• Clear Cell Line Origin: ACRO's cell line products are sourced from globally recognized and authoritative cell banks, ensuring clear and traceable origins. Comprehensive documentation is available to support global regulatory filings and project transfers, enabling customers to meet compliance requirements with confidence.
• Well-Defined Intellectual Property (IP) Rights： ACRO's cell lines are formally licensed from original rights holders, granting ACRO the authority to modify, develop, and commercialize related products. The modified cell lines have clear IP ownership, and ACRO holds the rights to further authorize these cell lines. Customers using ACRO's cell lines for drug development, regulatory submissions, or project transfers can eliminate future IP-related risks, ensuring a secure and compliant pathway for their projects.
• Global Commercial Authorization Support： ACRO's dedicated international IP and legal team provides end-to-end support to help customers secure global commercial usage rights for cell line products. This ensures smooth regulatory compliance worldwide, enabling customers to navigate complex legal landscapes and accelerate their drug development processes with peace of mind.
License Scope
| Cell Type | Description | Rights Officially Secured by ACRO |
|---|---|---|
| HEK 293 Cells | Derived from human embryonic kidney cells, this cell line exhibits strong transfection capability and efficiently expresses exogenous genes. It is commonly used for therapeutic antibody production, engineered antibody screening, and optimization. |
1. Commercial usage rights for the cell line 2. Rights to modify, derive, and develop the cell line, as well as global sales rights for cell line products 3. Global support for commercial license and usage |
| CHO Cells | Derived from Chinese hamster ovary (CHO) cells, this cell line exhibits high-efficiency protein expression and is widely used for therapeutic protein and antibody production. | |
| Jurkat Cells | Derived from the peripheral blood of a human acute T-cell leukemia patient, this cell line is highly sensitive to TCR signaling and is commonly used in tumor immunotherapy research and antibody efficacy studies. | |
| Raji Cells | Derived from human Burkitt lymphoma cells, this cell line expresses B-cell surface antigens and is commonly used in drug research for cancer treatment. |
Workflow
ACROBiosystems's Functional Cell Line Products
To address the evolving demands of new drug development, ACROBiosystems, leveraging its featured cell line development platform and extensive expertise in drug analysis assays and application technologies, has successfully developed over a hundred functional cell lines using HEK293, CHO, Jurkat, and Raji as host cells. These include reporter cell lines, overexpressing cell lines, and gene knockout cell lines. Additionally, ACROBiosystems' functional cell line team offers worry-free, one-stop customized cell line development services tailored to customer needs!
Product Advantages
Functional cell lines designed based on clear MOA for mechanism of action studies;
Higher sensitivity and larger detection window for robust and reproducible cell-based analytical applications;
Comprehensive application data to support analytical method development and validation;
Traceable cell lines with strict quality control and validated cell passage stability;
Parental cell lines legally sourced from internationally recognized cell resource banks with clear origins and commercial authorization;
Global commercial licensing support services to fully support customer regulatory filings.
- Introduction
- Core Value
- License Scope
- Workflow
- ACROBiosystems's Functional Cell Line Products